We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

AI Chip to Help Capture and Analyze Molecular Data in RT

By LabMedica International staff writers
Posted on 28 Nov 2017
Print article
Image: The system-on-chip is designed to yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms (Photo courtesy of Nano Global).
Image: The system-on-chip is designed to yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms (Photo courtesy of Nano Global).
Molecular data company Nano Global (Austin, TX, USA) is developing a chip using intellectual property (IP) from Arm Holdings (Cambridge, UK), a semiconductor IP company, to help redefine how global health challenges ranging from superbugs to infectious diseases, and cancer are conquered. The pioneering system-on-chip (SoC) will yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms.

The chip, combined with the company's scientific technology platform, leverages advances in nanotechnology, optics, artificial intelligence (AI), blockchain authentication, and edge computing to access and analyze molecular-level data in real time. The initial development of the chip is underway and the first delivery is expected by 2020, with the company having already begun adding new partners to their platform.

"In partnership with Arm, we're tackling the vast frontier of molecular data to unlock the unlimited potential of this universe," said Steve Papermaster, Chairman and CEO of Nano Global. "The data our technology can acquire and process will enable us to create a safer and healthier world."

"We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology," said Rene Haas, executive vice president and president of IPG, Arm. "By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges."

Nano Global will also be partnering with several leading institutions, including Baylor College of Medicine and National University of Singapore, on broad research initiatives in clinical, laboratory, and population health environments to accelerate data collection, analysis, and product development.

Related Links:
Nano Global
Arm Holdings

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.